• PCV23 Budget IMPACT Analysis of Sacubitril Valsartan for Heart Failure Treatment in Indonesia

    Sep 1, 2020, 00:00

  • PNS29 IMPACT of Pharmacoeconomic Evaluation Guidelines: A Systematic Review of Reporting Quality of Pharmacoeconomic Evaluations for NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PIN8 Analysis of Potential Cost-Savings after Introduction of 0.1% Polihexanide/Betaine Solution for Chronic Wounds in Reimbursement Healthcare System of Korea

    Sep 1, 2020, 00:00

  • PND27 Valuing Health States Using Discrete Choice Experiment: Case of Cerebral Palsy

    Sep 1, 2020, 00:00

  • PNS56 Effect of the Recall Period for Estimating Inpatient out-of-Pocket Expenditures: Validation Study in Vietnam

    Sep 1, 2020, 00:00

  • PMS17 Usability Testing of a Patient Engagement Digital Platform for TOTAL Knee Arthroplasty (TKA) Patients in JAPAN

    Sep 1, 2020, 00:00

  • PIN18 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in New Zealand

    Sep 1, 2020, 00:00

  • PND14 Identifying Patients with RARE Refractory Epilepsies in Japanese Health Databases: Feasibility for a Burden of Illness Study

    Sep 1, 2020, 00:00

  • PIN35 Evaluation of Effectiveness of Knowledge Transfer of Antimicrobial Resistance to Hong Kong Elderly: A Quasi-Experiment

    Sep 1, 2020, 00:00

  • PGI2 Quantitative Evaluation to Efficacy and Safety of Biosimilar of Infliximab in Inflammatory Bowel Diseases: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PND19 Economic and Social Factors Affecting Healthcare Expenditure for Households with Cerebrovascular Diseases

    Sep 1, 2020, 00:00

  • PNS31 Increased Cigarette Taxes and Quitting Behavior Among Adults

    Sep 1, 2020, 00:00

  • PDB12 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PNS64 Landscape Analysis of Studies in Asia Eliciting Patient Preferences for Therapeutic Interventions

    Sep 1, 2020, 00:00

  • PUK5 Remaining Waitlisted for a Superior Quality Kidney; An Economic Evaluation of Contemporary Transplant Practice

    Sep 1, 2020, 00:00

  • PCN39 Cost-Effectiveness of Brentuximab Vedotin for Relapsed or Refractory Systemic Anaplastic Large-CELL Lymphoma in China

    Sep 1, 2020, 00:00

  • PDG25 Drug Therapy Problem and Contributing Factors in Ethiopia: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN4 Aromatase Inhibitors and Bisphosphonate Use in Postmenopausal Women with Hormone-Receptor Positive Breast Cancer in Hong Kong

    Sep 1, 2020, 00:00

  • PNS10 Economic Evaluation in the Philippines before the Era of Mandatory Health Technology Assessment: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS24 Willingness-to-Pay Thresholds Applied for Health Economic Analyses in Oncology in China: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PBI3 The Economic Evaluation Of Clopidogrel In Antiplatelet Therapy Guided By CYP2C19 Gene Polymorphism In The Treatment Of Patients With Coronary Heart Disease

    Sep 1, 2020, 00:00

  • PCN71 Comparing the International Price of Anticancer Drugs and Improving Their Accessibility in South Korea

    Sep 1, 2020, 00:00

  • PCV5 Cost-Effectiveness Analysis of Apixaban in Treatment of Atrial Fibrillation: A Systematic Review

    Sep 1, 2020, 00:00

  • PDG18 Availability, Cost and Affordability of Selected Antibiotics and Antiviral Medicines Against Infectious Diseases from 2013 to 2019 in Nanjing, China

    Sep 1, 2020, 00:00

  • PNS51 The Role of Patients in Health Technology Assessment Process - Experience of Taiwan

    Sep 1, 2020, 00:00

  • PIN5 Evaluating Treatments and Corresponding Mortality Rates in Patients with Acinetobacter Baumannii Infections

    Sep 1, 2020, 00:00

  • PIN26 Assessment Of Influence Of Education To Parents Towards Completion Of Vaccination : A Randomised Controlled Study

    Sep 1, 2020, 00:00

  • PRS9 Economic Burden of Adult Patients with Asthma Using a CROSS-Sectional Analysis of Survey DATA in ASIA and the U.S

    Sep 1, 2020, 00:00

  • PIN33 Public Health Behaviour Changes during the Covid-19 Outbreak in China: A Comparison in Different Risk Groups

    Sep 1, 2020, 00:00

  • PCN25 Hospital Costs Associated with Powered and Manual Staplers in VIDEO-Assisted Thoracic Surgery Lobectomy for LUNG Cancer in a Chinese Teritary Care Hospital

    Sep 1, 2020, 00:00

  • PIN40 Influenza Vaccination in Adult Patients with Hypertension or Diabetes in South Korea: A CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PRS5 An Environment IMPACT Analysis of the Use of Respimat RE-Usable for the Treatment of Chronic-Obstructive Pulmonary Disorder (COPD) in South-EAST ASIA and South Korea

    Sep 1, 2020, 00:00

  • PNS13 Assessment of Satisfaction with New Competencies and Roles of Nurses in the Framework of Nursing Reform in Kazakhstan

    Sep 1, 2020, 00:00

  • PNS68 Valuating the CHILD Health Utility 9-Dimention in JAPAN: Results from a Nation-Wide School-Based Survey

    Sep 1, 2020, 00:00

  • PBI4 The ISSUE of Patient CO-Pay and Biosimilars in JPN: Is IT Really an ISSUE?

    Sep 1, 2020, 00:00

  • PCN93 A Comparison of Machine Learning (ML) Algorithms Performance Against Medical Professionals in Diagnosing LUNG Cancer: A Targeted Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN105 Investigating Medical Utilization in Ductal Carcinoma in Situ (DCIS) Women: A Real-World Data Analysis

    Sep 1, 2020, 00:00

  • PMU7 Drug-Drug Interaction ( DDI ) Pharmacoeconomic Studies of Waste. Experience of a Single Institution Based on Rwd at a Private Health Insurance in LATAM

    Sep 1, 2020, 00:00

  • PIN20 Study on Disease Treatment Preference and Willingness Payment in Hepatitis C Patients

    Sep 1, 2020, 00:00

  • PGI4 Projecting the Health Impact of Vaccination with Rotateq in China

    Sep 1, 2020, 00:00

  • PMH7 Depression and Insomnia at Burapha University, Thailand 2019

    Sep 1, 2020, 00:00

  • PCN23 Cost-Effectiveness Analysis of Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride, and paclitaxel As Second-LINE Chemotherapy in the Treatment of Platinum-Resistant Ovarian Cancer in Iran

    Sep 1, 2020, 00:00

  • PCN86 Predicting the Unknown - How Health Technology Assessment Agencies Deal with Uncertainty, and the IMPACT This HAS on Patient Access for Immuno-Oncology Therapies

    Sep 1, 2020, 00:00

  • PCN24 Budget IMPACT Analysis (BIA) of Introducing Tisagenlecleucel for the Treatment of Patients with Relapsed and Refractory Diffuse Large B-CELL Lymphoma (R/R DLBCL) in Singapore (SG)

    Sep 1, 2020, 00:00

  • PMS5 Incidence and Risk Factors for Subsequent Osteoporotic Fracture: A Nationwide Cohort Study in South Korea

    Sep 1, 2020, 00:00

  • PIH14 Perception of Seriousness, Knowledge, and Willingness to Pay for Cervical Cancer Screening Among Women in Yogyakarta Province, Indonesia

    Sep 1, 2020, 00:00

  • PMD14 Economic Analysis to Evaluate IMPACT of Prostheses Choice in Primary TOTAL Knee Arthroplasty

    Sep 1, 2020, 00:00

  • PMH15 Children with Deficit in Executive Abilities Have a Risk for Emerging Weakness in Grammar Understanding

    Sep 1, 2020, 00:00

  • PND7 Cost-Effectiveness of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Kazakhstan

    Sep 1, 2020, 00:00

  • PCN43 Disease Burden of NON-SMALL CELL Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMS2 Disease Burden of Subsequent Fracture in Osteoporosis Patients in South Korea

    Sep 1, 2020, 00:00

  • PCN88 HTA Evaluations of Oncology Drugs in APAC - Comparison of Trends and Drivers of Success in 5 Countries

    Sep 1, 2020, 00:00

  • PUK4 Cost-Effectiveness of Robotic-Assisted Partial Nephrectomy

    Sep 1, 2020, 00:00

  • PMU17 Health Technology Assessment for Procedures: The Evaluation of Innovation in JAPAN

    Sep 1, 2020, 00:00

  • PCN74 Analyze Oncology Drug Price Change in the Chinese Market through National Reimbursement Drug LIST Negotiation

    Sep 1, 2020, 00:00

  • PNS30 IMPACT of Cigarette Tax on Youth Smoking in Taiwan

    Sep 1, 2020, 00:00

  • PIN24 Disease Burden of Progressive Chronic Hepatitis C in China

    Sep 1, 2020, 00:00

  • PDG27 The Complexity and Cost of Drug Regimens for Hypertensive Patients in China

    Sep 1, 2020, 00:00

  • The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect? [Editor's Choice]

    Sep 1, 2020, 00:00

  • PMS16 Longitudinal Analyses of Health-Related Quality of Life and Daily Activities Function Among HIP Fracture Population: A Real-World Prospective Cohort Study

    Sep 1, 2020, 00:00

  • PMS4 Epidemiology, Treatment Patterns, and Economic Burden of Postmenopausal Osteoporosis and Associated Fractures in China in 2017

    Sep 1, 2020, 00:00

  • PCN53 Cost-Utility Analysis of Dacomitinib As First-LINE Treatment for Patients with Locally Advanced or Metastatic NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PCN13 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus S-1 PLUS Gemcitabine in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PCV11 Cost-Effectiveness of Intravascular Ultrasound (IVUS) during Drug-Eluting Stent Implantation in Korea

    Sep 1, 2020, 00:00

  • PCN58 Frequency of Myalgia in Patients Receiving Platinum Based Chemotherapy

    Sep 1, 2020, 00:00

  • Copyright/Subscription

    Jun 3, 2020, 09:04

  • Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

    May 1, 2020, 00:00

  • From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review

    May 1, 2020, 00:00

  • Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to Action

    May 1, 2020, 00:00

  • The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

    May 1, 2020, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals

    May 1, 2020, 00:00

  • Complicated Issues of Medical Examination: A Case Study of the Irkutsk Region

    May 1, 2020, 00:00

  • Tackling the 3 Big Challenges Confronting Health Technology Assessment Development in Asia: A Commentary

    May 1, 2020, 00:00

  • Causes of Under-5 Mortality Among Brazil, the Russian Federation, India, China, and South Africa Nations: A Comparative Study

    May 1, 2020, 00:00

  • Economic Evaluation of Breast Cancer Early Detection Strategies in Asia: A Systematic Review [Editor's Choice]

    May 1, 2020, 00:00

  • Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data

    May 1, 2020, 00:00

  • Relationships Between Pharmaceutical Therapy–Related Quality of Life and Health Utility Scores in Thai Patients With Chronic Diseases

    May 1, 2020, 00:00

  • Determining the Cost and Length of Stay at Intensive Care Units and the Factors Influencing Them in a Teaching Hospital in Malaysia

    May 1, 2020, 00:00

  • Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus

    May 1, 2020, 00:00

  • Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand

    May 1, 2020, 00:00

  • Editorial Board

    May 1, 2020, 00:00

  • The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System [Editor's Choice]

    May 1, 2020, 00:00

  • Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries

    May 1, 2020, 00:00

  • Inappropriate Rate of Admission and Hospitalization in the Iranian Hospitals: A Systematic Review and Meta-Analysis

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Prostate-Specific Antigen Screening Among Chinese Men

    May 1, 2020, 00:00

  • Translation, Cultural Adaptation, and Validation of Short-Form 6D on the General Population in Indonesia

    May 1, 2020, 00:00

  • The Economic Burden of Candidemia and Invasive Candidiasis: A Systematic Review

    May 1, 2020, 00:00

  • Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol

    May 1, 2020, 00:00

  • Estimation of Quality-Adjusted Life Expectancy of Patients With Oral Cancer: Integration of Lifetime Survival With Repeated Quality-of-Life Measurements

    May 1, 2020, 00:00

  • Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia

    May 1, 2020, 00:00

  • Budget Impact Analysis of Extended-Release Phenytoin Capsules Compared With Immediate-Release Phenytoin Capsules for Patients With Epilepsy in Thailand

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Xpert MTB/RIF for Multi-Outcomes of Patients With Presumptive Pulmonary Tuberculosis in Thailand [Editor's Choice]

    May 1, 2020, 00:00

  • Power of 1 Malaysian Ringgit: A Low-Cost Prescription Cost-Sharing Model in Malaysia

    May 1, 2020, 00:00

  • A Systematic Review of Equity in Healthcare Financing in Low- and Middle-Income Countries

    May 1, 2020, 00:00

  • Assessing the Low Influenza Vaccination Coverage Rate Among Healthcare Personnel in India: A Review of Obstacles, Beliefs, and Strategies

    May 1, 2020, 00:00

  • Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease

    May 1, 2020, 00:00

  • Kidney Disease–Specific Scores and Health Utility of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients and Their Caregivers

    May 1, 2020, 00:00

  • Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan

    May 1, 2020, 00:00

  • Survey on Willingness to Pay for Life-Saving Treatment, Functional Recovery, and Cosmesis in a Neuroscience Outpatient Clinic Setting in Singapore [Editor's Choice]

    May 1, 2020, 00:00

  • Association of Socioeconomic Status With Childhood Anemia Among Infant, Toddler, and Preschool Children in Bangladesh

    May 1, 2020, 00:00

  • Table of Contents

    May 1, 2020, 00:00

  • The Development of Health Technology Assessment in Asia: Current Status and Future Trends [Editor's Choice]

    May 1, 2020, 00:00

  • Cross-Cultural Adaptation and Psychometric Analysis of the Persian Version of the ICEpop CAPability Measure for Adults Capability Measure in the Iranian General Population

    May 1, 2020, 00:00

  • Population Aging, Technological Innovation, and the Growth of Health Expenditure: Evidence From Patients With Type 2 Diabetes in Taiwan

    May 1, 2020, 00:00

  • The Factors Associated With Direct Medical Costs in Patients With Gastric Cancer: Quantile Regression Approach Compared With Gamma Regression

    May 1, 2020, 00:00

  • The Structure and Parameterization of the Breast Cancer Transition Model Among Chinese Women

    May 1, 2020, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment

    May 1, 2020, 00:00

  • Copyright/Subscription

    Dec 16, 2019, 08:54

  • Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume–Based Analysis

    Dec 1, 2019, 00:00

  • Budgetary Impact of Oral Rehabilitation With Complete Dentures: An Economical Evaluation From São Paulo State, Brazil

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective

    Dec 1, 2019, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective

    Dec 1, 2019, 00:00

  • Burden of Disease Attributable to Obesity and Overweight in Colombia

    Dec 1, 2019, 00:00

  • Determining the Operating Costs of a Medical Surveillance Program for Copper Miners Exposed to High Altitude–Induced Chronic Intermittent Hypoxia in Chile Using a Combination of Microcosting and Time-Driven Activity-Based Costing

    Dec 1, 2019, 00:00

  • Editorial Board

    Dec 1, 2019, 00:00

  • Response to Letter to the Editor

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of a Technology-Enhanced Diabetes Care Management Program in Mexico

    Dec 1, 2019, 00:00

  • The Brazilian Portuguese Version of the DISCERN Instrument: Translation Procedures and Psychometric Properties

    Dec 1, 2019, 00:00

  • The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico [Editor's Choice]

    Dec 1, 2019, 00:00

  • Inflammatory Bowel Disease in Latin America: A Systematic Review

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Agnet y Judicialization en Salud en Argentina

    Dec 1, 2019, 00:00

  • Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology “Ignacio Chávez”

    Dec 1, 2019, 00:00

  • Prevalence of Symptoms and Symptom Clusters of Patients on Dialysis in Uruguay

    Dec 1, 2019, 00:00

  • Acuerdos de Riesgo Compartido: Lecciones Para su Diseño e Implementación a la Luz de la Experiencia Internacional

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia

    Dec 1, 2019, 00:00

  • Custo-utilidade de terapias-alvo comparadas à dacarbazina para o tratamento de primeira linha do melanoma avançado não-cirúrgico e metastático no Sistema Único de Saúde do Brazil

    Dec 1, 2019, 00:00

  • A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population [Editor's Choice]

    Dec 1, 2019, 00:00

  • The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia [Editor's Choice]

    Dec 1, 2019, 00:00

  • Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia

    Dec 1, 2019, 00:00

  • Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela

    Dec 1, 2019, 00:00

  • New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017

    Dec 1, 2019, 00:00

  • The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina

    Dec 1, 2019, 00:00

  • Budget Impact of Cryoablation Versus Radiofrequency Ablation of Atrial Fibrillation in the Brazilian Public Healthcare System

    Dec 1, 2019, 00:00

  • Beneficio económico de los ensayos clínicos controlados patrocinados: El gasto evitable en medicamentos para el tratamiento de la artritis reumatoidea

    Dec 1, 2019, 00:00

  • Health Economics and Outcomes Research Knowledge Needs Assessment for Latin America [Editor's Choice]

    Dec 1, 2019, 00:00

  • Costo de la intoxicación por Paraquat en Colombia

    Dec 1, 2019, 00:00

  • Table of Contents

    Dec 1, 2019, 00:00

  • Challenges in the Regulation of High-Cost Treatments: An Overview From Brazil [Editor's Choice]

    Dec 1, 2019, 00:00

  • Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis

    Dec 1, 2019, 00:00

  • The Price of Substitute Technologies

    Dec 1, 2019, 00:00

  • PND12 WORK PRODUCTIVITY AND DAILY ACTIVITIES IMPAIRMENT (WPAI) IN CHILEAN PATIENTS WITH MIGRAINE: PERSPECTIVES ON INDIRECT-COSTS DRIVERS

    Oct 1, 2019, 00:00

  • PIN4 A BUDGET IMPACTO ANALYSIS OF TENOFOVIR ALAFENAMIDE/EMTRICITABINE (DESCOVY®) FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN PATIENTS AGED 12 YEARS AND OLDER, IN MEXICO

    Oct 1, 2019, 00:00

  • PUK7 ANALISIS DE EFECTIVIDAD Y SEGURIDAD DE MIRABEGRON EN PACIENTES CON SINDROME DE VEJIGA HIPERACTIVA

    Oct 1, 2019, 00:00

  • PCN44 DESIGUALDADES EN EL DIAGNÓSTICO DE CÁNCER DE CÉRVIX EN LAS REGIONES DE COLOMBIA

    Oct 1, 2019, 00:00

  • PRO14 COMPARAR A INCIDÊNCIA DE COMORBIDADES NO TRATAMENTOS DE MIELOMA MÚLTIPLO ENTRE AS TERAPIAS DO SISTEMA DE SAÚDE BRASILEIRO (SUS) COM AS AINDA NÃO INCORPORADAS

    Oct 1, 2019, 00:00

  • PNS59 IMPACTO DEL MODELO DE RIESGO COMPARTIDO EN LA TASA DE EVENTOS HOSPITALARIOS DE UN SEGURO VOLUNTARIO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PND4 ANALISIS DE MINIMIZACION DE COSTOS DE TOPIRAMATO DE LIBERACION PROLONGADA PARA LA PREVENCION DE MIGRAÑA EN ADULTOS Y ADOLESCENTES A PARTIR DE LOS 12 AÑOS

    Oct 1, 2019, 00:00

  • PMH10 TREATMENT-RESISTANT DEPRESSION IN LATIN AMERICA: PRELIMINARY RESULTS FROM THE TRAL STUDY

    Oct 1, 2019, 00:00

  • PMS10 NATIONWIDE ANNUAL HEALTH INSURANCE TREATMENT COST OF JUVENILE AND ADOLESCENT IDIOPATHIC SCOLIOSIS IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • PNS15 DOES FOOD INSECURITY AFFECT PERFORMANCE AT SCHOOL? EVIDENCE FROM BRAZIL

    Oct 1, 2019, 00:00

  • PNS45 APPLYING A RAPID REVIEW METHODOLOGY TO INFORM THE UPDATE OF ARGENTINA'S HEALTH BENEFIT PACKAGE

    Oct 1, 2019, 00:00

  • PRO11 ANÁLISIS DE SERIE DE CASOS DE PACIENTES CON DIAGNÓSTICO DE HEMOFILIA A CON INHIBIDORES EN HOSPITALES DE ALTA COMPLEJIDAD EN ECUADOR

    Oct 1, 2019, 00:00

  • PIN26 PRINCIPALES ESQUEMAS ANTIRRETROVIRALES USADOS EN LAS PERSONAS QUE VIVEN CON EL VIH EN COLOMBIA. 2018

    Oct 1, 2019, 00:00

  • PDG10 DRUGS WITH DISCONTINUED PRODUCTION: A DESCRIPTIVE ANALYSIS OF THE BRAZILIAN SCENARIUM

    Oct 1, 2019, 00:00

  • PCN39 ACCESS TO MEDICAL INTERVENTIONS IN BRAZIL: THE ROLE OF CLINICAL RESEARCH AND OF HEALTH JUDICIALIZATION

    Oct 1, 2019, 00:00

  • PNS3 BRAZILIAN PHARMACEUTICAL INDUSTRY: THE IMPACT OF PUBLIC POLICIES AIMED AT FOSTERING LOCAL MANUFACTURING

    Oct 1, 2019, 00:00

  • PCN30 REAL-WORLD DATA FOR COSTS RELATED TO CANCER MANAGEMENT IN BRAZIL: AN OVERVIEW OF THE LITERATURE

    Oct 1, 2019, 00:00

  • PDB10 COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES MELLITUS COMPARED WITH MULTIPLE DAILY INJECTIONS IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • HI4 ADHERENCE TO TREATMENT IS ASSOCIATED WITH GOOD CLINICAL RESULTS IN PATIENTS TREATED WITH BIOLOGICAL THERAPY IN A CENTER OF EXCELLENCE IN RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PCN13 EVENTOS ADVERSOS ASOCIADOS A LOS TRATAMIENTOS DEL CARCINOMA UROTERIAL DE VEJIGA Y EL CARCINOMA DE CELULAS RENALES: ESTIMACION DE COSTOS DIRECTOS PARA ARGENTINA

    Oct 1, 2019, 00:00

  • PCN24 COST-EFFECTIVENESS OF NIVOLUMAB COMBINED WITH IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA FOR PATIENTS WITH BRAF+ MUTATION FROM A BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PIN20 OVERVIEW OF MORTALITY DUE TO ANTIMICROBIAL RESISTANT INFECTIONS

    Oct 1, 2019, 00:00

  • PRO9 PUBLIC PURCHASES OF ECULIZUMABE BY THE BRAZILIAN MINISTRY OF HEALTH: A PROFILE OF VOLUMES AND EXPENSES FROM 2007 TO 2018

    Oct 1, 2019, 00:00

  • PMS8 CONVENTIONAL VERSUS BIOLOGICAL TREATMENT FOR ANKYLOSING SPONDYLITIS. RESULTS FROM A REAL-LIFE SETTING

    Oct 1, 2019, 00:00

  • MT2 REMOTE MONITORING COMPARED TO CONVENTIONAL FOLLOW-UP FOR PATIENTS WITH HEART FAILURE USING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: A BUDGET IMPACT ANALYSIS

    Oct 1, 2019, 00:00

  • PGI5 BURDEN OF LIVER DISEASE, COLOMBIA 2009-2016

    Oct 1, 2019, 00:00

  • HI1 PRELIMINARY COST ANALYSIS OF MISDIAGNOSIS OF RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PCV2 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN ARGENTINA: META-ANALYSIS OF REAL-LIFE DATA

    Oct 1, 2019, 00:00

  • PAM2 GESTION DE SOPORTE NUTRICIONAL EN CUIDADOS INTENSIVOS

    Oct 1, 2019, 00:00

  • PCN20 COSTO EFECTIVIDAD DE LA UTILIZACIÓN DE INHIBIDORES DE PUNTOS DE CONTROL INMUNITARIO (ANTI-PD1/ANTI-CTLA4) Y TERAPIAS DIRIGIDAS (BRAFI/MEKI) EN EL TRATAMIENTO DEL MELANOMA AVANZADO.

    Oct 1, 2019, 00:00

  • PCN15 IMPACTO ECONOMICO DE LAS COMPLICACIONES OSEAS EN PACIENTES CON CANCER DE MAMA METASTASICO (CAMM) EN MEXICO.

    Oct 1, 2019, 00:00

  • PMH6 COST-EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS FOR FIRST- AND SECOND-LINE TREATMENT OF SCHIZOPHRENIA IN BRAZIL

    Oct 1, 2019, 00:00

  • PIH2 COST-EFFECTIVENESS ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PAM6 COMPLEMENTARY AND INTEGRATIVE THERAPIES IN BRAZIL'S UNIFIED HEALTHCARE SYSTEM (SUS) IN 2017: AN UNDERREPORTING CASE

    Oct 1, 2019, 00:00

  • PRO1 MEDICAL THERAPY FOR PULMONARY ARTERIAL HYPERTENSION (PAH): AN INDIRECT TREATMENT COMPARISON OF MACITENTAN AND BOSENTAN

    Oct 1, 2019, 00:00

  • PCN23 IMPACTO ECONOMICO DE CANCER DE CUELLO UTERINO Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PMU9 ESTABLISHING CHILE RICARTE SOTO LAW REIMBURSEMENT CAP IN THE FACE OF GENERIC COMPETITION

    Oct 1, 2019, 00:00

  • PIH8 MODEL TO APPROACH TO THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY IN CHILE: THE IMPACT OF THE FAILURE OF COMPLIANCE OF THE CONTRACEPTIVE METHODS.

    Oct 1, 2019, 00:00

  • PNS10 THE PENALTY OF MATERNITY FOR LABOR MARKET IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS7 THE PRICE OF SUBSTITUTE TECHNOLOGIES

    Oct 1, 2019, 00:00

  • PIN10 PUBLIC HEALTH AND ECONOMIC IMPACT OF A HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • PNS20 REPORTS OF SUBSTANDARD MEDICINES: AN ANALYSIS OF THE BRAZILIAN HEALTH SURVEILLANCE NOTIFICATION SYSTEM

    Oct 1, 2019, 00:00

  • PND14 OUT-OF-POCKET EXPENDITURE IN MIGRAINE PATIENTS WITH AND WITHOUT COMORBIDITIES IN CHILE: A HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PCN33 PERTUZUMAB+TRASTUZUMAB TREATMENT ON HER2+ EARLY BREAST CANCER: LONG-TERM REDUCTION OF METASTASIC BREAST CANCER INCIDENCE IN ARGENTINA.

    Oct 1, 2019, 00:00

  • PMS17 PATIENT PREFERENCES FOR BIOLOGIC AND BIOSIMILAR OSTEOPOROSIS TREATMENTS IN COLOMBIA: A DISCRETE-CHOICE EXPERIMENT

    Oct 1, 2019, 00:00

  • CV1 CARDIOVASCULAR RISK IN DIABETES PATIENTS MONITORED BY A MOBILE PHONE APP HEALTH CARE PROGRAM IN BRAZIL

    Oct 1, 2019, 00:00

  • PMU13 A MULTI-CRITERIA APPROACH TO THE STUDY OF CHRONIC NON-COMMUNICABLE DISEASES IN BRAZIL

    Oct 1, 2019, 00:00

  • PSU6 ESTUDIO DE COSTO EFECTIVIDAD ENTRE HEPARINA NO FRACCIONADA Y HEPARINAS DE BAJO PESO MOLECULAR EN PACIENTES SOMETIDOS A ARTROPLASTIA TOTAL DE CADERA ELECTIVA

    Oct 1, 2019, 00:00

  • PCN42 JUDICIALIZATION OF ACCESS TO MEDICINES IN ONCOLOGY: SYSTEMATIZED REVIEW

    Oct 1, 2019, 00:00

  • PMD13 BUNDLE AND RISK SHARING FOR BARIATRIC SURGERY UNDER THE VALUE-BASED CARE (VBC) MODEL: MODEL EFFECTIVENESS AND SUSTAINABILITY AT HOSPITAL ALEMAO OSWALDO CRUZ (HAOC) BASED IN CLINICAL AND ECONOMICAL RESULTS

    Oct 1, 2019, 00:00

  • PNS43 ESTIMACIÓN DE UN COSTO DE REFERENCIA PARA EVENTOS HOSPITALARIOS MEDIANTE NORMALIZACIÓN DE DATOS

    Oct 1, 2019, 00:00

  • PBI1 THE VALUE OF ONASEMNOGENE ABEPARVOVEC (AVXS-101) AS A COST-EFFECTIVE GENE REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 IN IMPROVING SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND MOTOR FUNCTION

    Oct 1, 2019, 00:00

  • PCV6 ECONOMIC EVALUATION OF GLOBAL LONGITUDINAL STRAIN IN THE EARLY DETECTION OF CARDIOTOXICITY IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PIN28 COSTS OF PERTUSSIS IN BRAZIL: A NINE-YEAR EVALUATION

    Oct 1, 2019, 00:00

  • PND6 THE DIRECT COSTS OF MULTIPLE SCLEROSIS IN A GROUP OF COLOMBIAN PATIENTS

    Oct 1, 2019, 00:00

  • PBI3 ANÁLISIS DEL COSTO POR RESPONDEDOR DE SECUKINUMAB VS INFLIXIMAB Y ETANERCEPT PARA EL TRATAMIENTO DE LA ARTRITIS PSORIÁSICA DESDE UNA PERSPECTIVA ECUATORIANA

    Oct 1, 2019, 00:00

  • PMU10 RESULTADOS DE IMPLEMENTACION DE PROGRAMA DE CUIDADOS PALIATIVOS EN UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN16 COST ESTIMATE ANALYSIS OF ABIRATERONE PLUS PREDNISONE (AAP) AND ENZALUTAMIDE (ENZ) IN INSURED METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS IN ARGENTINA: EVIREPRO DATABASE

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • »